Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası:
- Basım Tarihi: 2025
- Doi Numarası: 10.1200/jco-25-01957
- Dergi Adı: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
- Ankara Üniversitesi Adresli: Evet